Distribution of


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 02 01 2020
accepted: 20 04 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 7 4 2021
Statut: epublish

Résumé

Donor-specific antibodies (DSAs) are the main risk factor for antibody-mediated rejection (ABMR) and graft loss but could have variable pathogenicity according to their IgG subclass composition. Luminex-based test might lack sensitivity for the detection of IgG subclasses and this test does not allow quantifying the relative abundance of each IgG subclass. We investigated the precise repartition of each DSA subclass and their role in ABMR occurrence and severity, using an innovative mass spectrometry-based method. Between 2014 and 2018, we enrolled 69 patients who developed

Identifiants

pubmed: 32670261
doi: 10.3389/fimmu.2020.00919
pmc: PMC7326073
doi:

Substances chimiques

Biomarkers 0
Immunoglobulin G 0
Isoantibodies 0

Banques de données

ClinicalTrials.gov
['NCT04026087']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

919

Informations de copyright

Copyright © 2020 Pernin, Beyze, Szwarc, Bec, Salsac, Perez-Garcia, Mourad, Merville, Visentin, Perrochia, Larroque, Couzi and Le Quintrec.

Références

Clin Transplant. 2018 Jun;32(6):e13266
pubmed: 29676812
J Transplant. 2018 Apr 23;2018:8316860
pubmed: 29850195
Pediatr Transplant. 2018 Aug;22(5):e13219
pubmed: 29855114
Am J Transplant. 2012 Feb;12(2):388-99
pubmed: 22081892
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Adv Immunol. 1993;54:229-70
pubmed: 8379463
J Immunol. 2008 Aug 1;181(3):1767-79
pubmed: 18641314
Eur J Immunol. 1991 Jan;21(1):11-6
pubmed: 1703960
Clin Chem. 2014 Aug;60(8):1080-8
pubmed: 24799527
J Proteome Res. 2016 Oct 7;15(10):3550-3562
pubmed: 27546623
Am J Transplant. 2015 Apr;15(4):1003-13
pubmed: 25772599
Transplantation. 2013 May 15;95(9):1113-9
pubmed: 23514959
Transplantation. 2011 Sep 15;92(5):510-5
pubmed: 21869744
Nat Rev Nephrol. 2012 Nov;8(11):670-8
pubmed: 23026942
Transplantation. 2015 Jun;99(6):1151-5
pubmed: 25839705
Am J Transplant. 2012 May;12(5):1157-67
pubmed: 22429309
Am J Transplant. 2018 Feb;18(2):293-307
pubmed: 29243394
Transplantation. 2013 Feb 15;95(3):410-7
pubmed: 23380861
Liver Transpl. 2012 Aug;18(8):984-92
pubmed: 22508525
Am J Transplant. 2017 Jun;17(6):1574-1584
pubmed: 27977905
Hum Immunol. 2013 May;74(5):666-72
pubmed: 23369861
N Engl J Med. 2013 Sep 26;369(13):1215-26
pubmed: 24066742
Transplantation. 2011 Jul 15;92(1):41-7
pubmed: 21637140
J Proteomics. 2015 Feb 26;116:24-33
pubmed: 25582524
Transplantation. 2014 Sep 27;98(6):625-31
pubmed: 25058376
Nephrol Dial Transplant. 2018 Oct 1;33(10):1853-1863
pubmed: 29672702
Adv Pediatr. 1992;39:101-26
pubmed: 1442311
Semin Immunol. 1994 Oct;6(5):295-301
pubmed: 7532459
N Engl J Med. 1980 Jul 24;303(4):178-82
pubmed: 6966763
J Am Soc Nephrol. 2018 Feb;29(2):606-619
pubmed: 29255058
J Proteome Res. 2018 Jan 5;17(1):222-233
pubmed: 29207246
J Am Soc Nephrol. 2017 Jun;28(6):1912-1923
pubmed: 28255002
J Immunol. 1983 Feb;130(2):722-6
pubmed: 6600252
Transpl Int. 2015 Dec;28(12):1405-15
pubmed: 26264744
Transplantation. 2014 Mar 15;97(5):494-501
pubmed: 24487396
J Am Soc Nephrol. 2016 Jan;27(1):293-304
pubmed: 26293822
J Am Soc Nephrol. 2010 Aug;21(8):1398-406
pubmed: 20634297
Blood. 2009 Apr 16;113(16):3716-25
pubmed: 19018092

Auteurs

Vincent Pernin (V)

Department of Nephrology, Dialysis and Transplantation, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Anais Beyze (A)

Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Ilan Szwarc (I)

Department of Nephrology, Dialysis and Transplantation, Montpellier University Hospital, University of Montpellier, Montpellier, France.

Nicole Bec (N)

Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Céline Salsac (C)

Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Esther Perez-Garcia (E)

Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Georges Mourad (G)

Department of Nephrology, Dialysis and Transplantation, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Pierre Merville (P)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Pellegrin University Hospital, Bordeaux, France.
Immuno ConcEpT, UMR CNRS 5164, Bordeaux, France.
Université de Bordeaux, Bordeaux, France.

Jonathan Visentin (J)

Immuno ConcEpT, UMR CNRS 5164, Bordeaux, France.
Université de Bordeaux, Bordeaux, France.
Department of Immunology and Immunogenetics, Pellegrin University Hospital, Bordeaux, France.

Helene Perrochia (H)

Department of Pathology, Montpellier University Hospital, Montpellier, France.

Christian Larroque (C)

Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Montpellier University, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.

Lionel Couzi (L)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Pellegrin University Hospital, Bordeaux, France.
Immuno ConcEpT, UMR CNRS 5164, Bordeaux, France.
Université de Bordeaux, Bordeaux, France.

Moglie Le Quintrec (M)

Department of Nephrology, Dialysis and Transplantation, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, INSERM, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH